Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas

The radiolabeled amino acid positron emission tomography (PET) imaging of gliomas is increasingly used for diagnostic and prognostic purposes, both for treatment planning and for tumor monitoring (whether under oncological treatment or without any treatment), including the specific diagnosis of glioma recurrence [1–5]. The Response Assessment in Neuro-Oncology (RANO) working group has recommended its use in these settings as a complement to standard magnetic resonance imaging (MRI)...

Actu précédente
Actu suivante